OncoCyte Corporation (OCX)
| Bid | 3.06 |
| Market Cap | 67.08M |
| Revenue (ttm) | 1.09M |
| Net Income (ttm) | -66.26M |
| EPS (ttm) | -4.44 |
| PE Ratio (ttm) | -0.72 |
| Forward PE | -1.17 |
| Analyst | Hold |
| Ask | 3.19 |
| Volume | 102,252 |
| Avg. Volume (20D) | 86,491 |
| Open | 2.70 |
| Previous Close | 2.78 |
| Day's Range | 2.63 - 3.19 |
| 52-Week Range | 1.92 - 3.48 |
| Beta | 0.90 |
About OCX
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support...
Analyst Forecast
According to 3 analyst ratings, the average rating for OCX stock is "Hold." The 12-month stock price forecast is $4.25, which is an increase of 33.44% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · prismmediawire.com
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical OfficerIrvine, Calif., Jan. 8, 2025 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announces the appointment of Dr. Paul Billings as the company's Consulting Chief Medica...
2 months ago · prismmediawire.com
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor MeetingsJanuary 13-16, 2025, San Francisco, CA IRVINE, Calif., December 9, 2024 – PRISM MediaWire – Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executiv...
2 months ago · prismmediawire.com
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New StudyIRVINE, Calif., Dec. 04, 2024 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay.